News & Updates
Showing Neurology articles
Showing
Show Multimedia Only

Can losartan delay the progression of AD?
13 Dec 2021
byAudrey Abella
In individuals with clinically diagnosed mild-to-moderate Alzheimer’s disease (AD), treatment with the angiotensin II receptor blocker (ARB) losartan for 12 months did not reduce the rate of brain atrophy, findings from the phase II RADAR* trial suggest.
13 Dec 2021

Low-dose aspirin does not stave off dementia
10 Dec 2021
byRoshini Claire Anthony
A daily 100 mg dose of aspirin for 7 years did not reduce the risk of dementia in individuals with diabetes and no history of cardiovascular disease (CVD), according to results of the ASCEND* study presented at AHA 2021.
10 Dec 2021

Cholinesterase inhibitors show promise for treating gait disturbance in PD
07 Dec 2021
Treatment with cholinesterase inhibitors in patients with Parkinson’s disease (PD) leads to significant improvements in gait variability, with trending benefits for gait speed and fall prevention, according to the results of a meta-analysis.
07 Dec 2021





